WALD
Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.
Waldencast plc (WALD) is rated C+ (2.5/5) on Deltasharpe Prism, scored against Consumer Defensive sector peers. Its strongest pillar is Value (B-); its weakest is Growth (D+). The rating has held at C+ for 5 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-15 | B- (3.1) | D+ (1.6) | C+ (2.7) | C+ (2.5) | C+ (2.6) | C+ (2.5) |
| 2026-11-08 | B- (3.1) | D+ (1.6) | B- (2.9) | C+ (2.5) | C+ (2.5) | C+ (2.5) |
| 2026-11-01 | B (3.2) | D+ (1.8) | C+ (2.8) | C+ (2.5) | C+ (2.5) | C+ (2.6) |
| 2026-10-25 | B (3.2) | D+ (1.8) | C+ (2.8) | C+ (2.5) | C (2.4) | C+ (2.5) |
| 2026-10-18 | B (3.2) | D+ (1.8) | C+ (2.8) | C+ (2.5) | C (2.4) | C+ (2.5) |